Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH

被引:36
|
作者
Tritschler, Tobias [1 ,2 ]
Kraaijpoel, Noemie [3 ]
Girard, Philippe [4 ,5 ]
Buller, Harry R. [3 ]
Langlois, Nicole [1 ]
Righini, Marc [6 ]
Schulman, Sam [7 ,8 ]
Segers, Annelise [9 ]
Le Gal, Gregoire [1 ]
机构
[1] Univ Ottawa, Ottawa Hosp Res Inst, Dept Med, Ottawa, ON, Canada
[2] Univ Bern, Bern Univ Hosp, Inselspital, Dept Gen Internal Med, Bern, Switzerland
[3] Univ Amsterdam, Amsterdam UMC, Dept Vasc Med, Amsterdam, Netherlands
[4] Inst Thorax Curie Montsouris, Paris, France
[5] Inst Mutualiste Montsouris, Paris, France
[6] Geneva Univ Hosp, Fac Med, Div Angiol & Hemostasis, Geneva, Switzerland
[7] McMaster Univ, Dept Med, Hamilton, ON, Canada
[8] First IM Sechenov Moscow State Med Univ, Dept Obstet & Gynecol, Moscow, Russia
[9] Acad Res Org, ITREAS, Amsterdam, Netherlands
基金
加拿大健康研究院;
关键词
cause of death; classification; mortality; pulmonary embolism; venous thromboembolism;
D O I
10.1111/jth.14769
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary embolism (PE)-related death is often a component of the primary outcome in venous thromboembolism (VTE) clinical studies. Definitions for PE-related death vary widely, which may lead to biased risk estimates of clinical outcomes, thereby affecting both internal and external validity of study results. We here provide a standardized definition of PE-related death and propose guidance for classification and reporting of the cause of death for clinical studies in VTE. The proposal was developed in a four-step process, including a systematic review of definitions used for PE-related death in previous studies, two subsequent surveys with VTE experts, and meetings held within the Scientific and Standardization Committee (SSC) working group until consensus on the proposal was reached. The proposed classification comprises three categories: Category A: PE-related death, category B: undetermined cause of death, and category C: cause of death other than PE. Category A includes A1: autopsy-confirmed PE in the absence of another more likely cause of death; A2: objectively confirmed PE before death in the absence of another more likely cause of death; and A3: PE is not objectively confirmed, but is most likely the main cause of death. Category B includes B1: cause of death is undetermined, despite available information; and B2: insufficient clinical information available to determine the cause of death. The use of the proposed definition will hopefully improve the accuracy of study outcomes, between-study comparisons, meta-analyses, and validity of future clinical VTE studies.
引用
收藏
页码:1495 / 1500
页数:6
相关论文
共 36 条
  • [21] Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation
    Martin, Karlyn A.
    Beyer-Westendorf, Jan
    Davidson, Bruce L.
    Huisman, Menno V.
    Sandset, Per Morten
    Moll, Stephan
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (08) : 1874 - 1882
  • [22] ORAL CONTRACEPTIVES AND RELATIVE RISK OF DEATH FROM VENOUS AND PULMONARY THROMBOEMBOLISM IN UNITED STATES
    SEIGEL, DG
    MARKUSH, RE
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 90 (01) : 11 - &
  • [23] Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database
    Barco, Stefano
    Valerio, Luca
    Ageno, Walter
    Cohen, Alexander T.
    Goldhaber, Samuel Z.
    Hunt, Beverley J.
    Iorio, Alfonso
    Jimenez, David
    Klok, Frederikus A.
    Kucher, Nils
    Mahmoudpour, Seyed Hamidreza
    Middeldorp, Saskia
    Munzel, Thomas
    Tagalakis, Vicky
    Wendelboe, Aaron M.
    Konstantinides, Stavros, V
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (01): : 33 - 42
  • [24] HOSPITALIZATIONS, RECURRENT VENOUS THROMBOEMBOLISM OR VENOUS THROMBOEMBOLISM-RELATED DEATH, AND MAJOR BLEEDING, BY INDEX EVENT FROM THE AMPLIFY TRIAL
    Lee, Theodore
    Masseria, Cristina
    Breazna, Andrei
    DiRusso, Gregory
    Hamilton, Melissa
    Horblyuk, Ruslan
    Mardekian, Jack
    Porcari, Anthony
    Cohen, Alexander
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2256 - 2256
  • [25] Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
    de Jong, Cindy M. M.
    de Wit, Kerstin
    Black, Stephen A.
    Gwozdz, Adam M.
    Masias, Camila
    Parks, Anna L.
    Robert-Ebadi, Helia
    Talerico, Rosa
    Woller, Scott C.
    Klok, Frederikus A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (10) : 2953 - 2962
  • [26] PREVENTIVE AND THERAPEUTIC APPROACH TO VENOUS THROMBOEMBOLIC DISEASE AND PULMONARY-EMBOLISM - CAN DEATH FROM PULMONARY-EMBOLISM BE PREVENTED
    KAKKAR, VV
    ADAMS, PC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) : B146 - B158
  • [27] Recommendations for standardized risk factor definitions in pediatric hospital-acquired venous thromboembolism to inform future prevention trials: communication from the SSC of the ISTH
    Branchford, B. R.
    Mahajerin, A.
    Raffini, L.
    Chalmers, E.
    van Ommen, C. H.
    Chan, A. K. C.
    Goldenberg, N. A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (11) : 2274 - 2278
  • [28] Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
    Kaatz, S.
    Ahmad, D.
    Spyropoulos, A. C.
    Schulman, S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (11) : 2119 - 2126
  • [29] Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis
    Whitworth, Hilary
    Amankwah, Ernest K.
    Betensky, Marisol
    Castellucci, Lana A.
    Cuker, Adam
    Goldenberg, Neil A.
    Male, Christoph
    Rinzler, Elliot
    Zia, Ayesha
    Raf, Leslie
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (06) : 1666 - 1673
  • [30] Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
    den Exter, Paul L.
    Woller, Scott C.
    Robert-Ebadi, Helia
    Masias, Camila
    Morange, Pierre-Emmanuel
    Castelli, David
    Hansen, John-Bjarne
    Geersing, Geert-Jan
    Siegal, Deborah M.
    de Wit, Kerstin
    Klok, Frederikus A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (08) : 1910 - 1919